These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37989214)

  • 1. Leptomeningeal Carcinomatosis from Solid Tumor Malignancies: Treatment Strategies and Biomarkers.
    Malani R; Bhatia A; Warner AB; Yang JT
    Semin Neurol; 2023 Dec; 43(6):859-866. PubMed ID: 37989214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptomeningeal metastasis from solid tumors.
    Thakkar JP; Kumthekar P; Dixit KS; Stupp R; Lukas RV
    J Neurol Sci; 2020 Apr; 411():116706. PubMed ID: 32007755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape.
    Nguyen A; Nguyen A; Dada OT; Desai PD; Ricci JC; Godbole NB; Pierre K; Lucke-Wold B
    Curr Oncol; 2023 Jun; 30(6):5906-5931. PubMed ID: 37366925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leptomeningeal disease.
    Groves MD
    Neurosurg Clin N Am; 2011 Jan; 22(1):67-78, vii. PubMed ID: 21109151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
    Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
    Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review of craniospinal irradiation for leptomeningeal disease: past, present, and future.
    Maillie L; Salgado LR; Lazarev S
    Clin Transl Oncol; 2021 Oct; 23(10):2109-2119. PubMed ID: 33881707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Newer avenues for the treatment of leptomeningeal carcinomatosis.
    Meriggi F; Zaniboni A
    Cent Nerv Syst Agents Med Chem; 2011 Mar; 11(1):38-44. PubMed ID: 21250935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptomeningeal Metastases in Melanoma Patients: An Update on and Future Perspectives for Diagnosis and Treatment.
    Steininger J; Gellrich FF; Engellandt K; Meinhardt M; Westphal D; Beissert S; Meier F; Glitza Oliva IC
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel approaches to treating leptomeningeal metastases.
    Grewal J; Saria MG; Kesari S
    J Neurooncol; 2012 Jan; 106(2):225-34. PubMed ID: 21874597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case report of prostate cancer with leptomeningeal metastasis.
    Dehghani M; PeyroShabany B; Shahraini R; Fazilat-Panah D; Hashemi F; Welsh JS; Javadinia SA
    Cancer Rep (Hoboken); 2022 Aug; 5(8):e1463. PubMed ID: 34089302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leptomeningeal carcinomatosis. How does cancer reach the pia-arachnoid?
    Kokkoris CP
    Cancer; 1983 Jan; 51(1):154-60. PubMed ID: 6336971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptomeningeal Carcinomatosis: Molecular Landscape, Current Management, and Emerging Therapies.
    Bhambhvani HP; Rodrigues AJ; Umeh-Garcia MC; Hayden Gephart M
    Neurosurg Clin N Am; 2020 Oct; 31(4):613-625. PubMed ID: 32921356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial of proton craniospinal irradiation for leptomeningeal metastases.
    Yang TJ; Wijetunga NA; Yamada J; Wolden S; Mehallow M; Goldman DA; Zhang Z; Young RJ; Kris MG; Yu HA; Seidman AD; Gavrilovic IT; Lin A; Santomasso B; Grommes C; Piotrowski AF; Schaff L; Stone JB; DeAngelis LM; Boire A; Pentsova E
    Neuro Oncol; 2021 Jan; 23(1):134-143. PubMed ID: 32592583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Craniospinal irradiation in the treatment of chemotherapy refractory leptomeningeal metastasis from breast cancer: A case report.
    Tesolin D; Vergidis D; Ramchandar K
    Cancer Rep (Hoboken); 2022 Jul; 5(7):e1556. PubMed ID: 34761557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery in leptomeningeal disease: Navigating barriers and beyond.
    Arshad N; Biswas N; Gill J; Kesari S; Ashili S
    Drug Deliv; 2024 Dec; 31(1):2375521. PubMed ID: 38995190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal chemotherapy.
    Kerr JZ; Berg S; Blaney SM
    Crit Rev Oncol Hematol; 2001 Mar; 37(3):227-36. PubMed ID: 11248578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy for leptomeningeal disease in breast cancer.
    Bartsch R; Jerzak KJ; Larrouquere L; Müller V; Le Rhun E
    Cancer Treat Rev; 2024 Jan; 122():102653. PubMed ID: 38118373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptomeningeal metastases: rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy?
    Siegal T
    J Neurooncol; 1998; 38(2-3):151-7. PubMed ID: 9696366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Most common sites on MRI of intracranial neoplastic leptomeningeal disease.
    Debnam JM; Mayer RR; Chi TL; Ketonen L; Weinberg JS; Wei W; Groves MD; Guha-Thakurta N
    J Clin Neurosci; 2017 Nov; 45():252-256. PubMed ID: 28802798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases.
    Wilcox JA; Boire AA
    CNS Drugs; 2023 Jan; 37(1):45-67. PubMed ID: 36474108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.